Shigeno Y, Koga H, Nagasawa M, Tanaka H, Fukuda Y, Tomonaga A, Suzuyama Y, Yamaguchi K, Izumikawa K, Saito A
Jpn J Antibiot. 1985 Sep;38(9):2547-57.
Twenty-six patients with bacterial infections, mainly respiratory infections, were treated with newly developed gamma-globulin preparation (SM-4300), as a combination therapy with some antibiotics. The result was as follows. Clinical effects of 18 cases evaluated were excellent in 1 case (5.6%), good in 10 (55.6%), fair in 4 (22.2%) and poor in 3 (16.7%). No remarkable adverse reactions and abnormal value in laboratory data due to administration of SM-4300 were observed. Significant changes of complement system before and after administration of SM-4300 were not observed. It was considered that SM-4300 was effective as a combination therapy with some antibiotics for the treatment of severe or refractory bacterial infections.
26例主要为呼吸道感染的细菌感染患者接受了新研发的γ-球蛋白制剂(SM-4300)治疗,并与某些抗生素联合使用。结果如下。在评估的18例患者中,临床疗效为优的有1例(5.6%),良的有10例(55.6%),中(尚可)的有4例(22.2%),差的有3例(16.7%)。未观察到因使用SM-4300而出现的明显不良反应及实验室数据异常值。未观察到使用SM-4300前后补体系统的显著变化。认为SM-4300作为与某些抗生素联合治疗严重或难治性细菌感染是有效的。